FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to dermatology and can be used for treating atopic dermatitis in children being residents of technogenic chemical environments with increased body biological environment contamination. This is ensured by standard background therapy together with intravenous drop-by-drop administration of cytoflavinum every day at 1 ml per 10 kg of child's body weight, dissolved in 150-200 ml of 0.9 % sodium chloride at 30-40 drops a minute for 3-7 days.
EFFECT: method provides higher clinical effectiveness ensured by reduced intensity of systemic inflammatory process in the body, improved metabolic processes, activated enzyme system, normalised immunogram values.
2 tbl, 1 dwg
